Cardiac myocyte contractility, calcium dynamics, and morphology in Zucker diabetic fatty female and male rats – lacking data in this model of obesity and diabetes: A review
References
- Bhatt NM, Aon MA, Tocchetti CG, Shen X, Dey S, Ramirez-Correa G, O’Rourke B, Gao WD, Cortassa S. Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose. Am J Physiol Heart Circ Physiol 308, H291–H302, 2014.
- Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138, 271–281, 2018.
- Clark JB, Palmer CJ, Shaw WN. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173, 68–75, 1983.
- Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141–148, 1978.
- da Silva BA, Bjorbaek C, Uotani S, Flier JS. Functional properties of leptin receptor isoforms containing the gln-->pro extracellular domain mutation of the fatty rat. Endocrinology 139, 3681–3690, 1998.
- Daniels A, Linz D, van Bilsen M, Rutten H, Sadowski T, Ruf S, Juretschke HP, Neumann-Haefelin C, Munts C, van der Vusse GJ, van Nieuwenhoven FA. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats. Eur J Heart Fail 14, 193–201, 2012.
- Daniels LJ, Wallace RS, Nicholson OM, Wilson GA, McDonald FJ, Jones PP, Baldi JC, Lamberts RR, Erickson JR. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats. Cardiovasc Diabetol 17, 89, 2018.
- Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GAJ, Kromer EP, Weil J. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 13, 11–19, 2004.
- Fredersdorf S, Thumann C, Zimmermann WH, Vetter R, Graf T, Luchner A, Riegger GA, Schunkert H, Eschenhagen T, Weil J. Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data. Cardiovasc Diabetol 11, 57, 2012.
- Fulop N, Mason MM, Dutta K, Wang P, Davidoff AJ, Marchase RB, Chatham JC. Impact of type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am J Physiol Cell Physiol 292, C1370–1378, 2007.
- Howarth FC, Qureshi MA, Hassan Z, Al Kury LT, Isaev D, Parekh K, Yammahi SRKD, Oz M, Adrian TE, Adeghate E. Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart. Exp Physiol 96, 325–337, 2011.
- Howarth FC, Qureshi MA, Hassan Z, Isaev D, Parekh K, John A, Oz M, Raza H, Adeghate E Adrian TE. Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca2+ transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart. Mol Cell Biochem 361, 267–280, 2012.
- Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34, 29–34, 1974.
- Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 24, S317–S320, 1994.
- Kozma M, Bombicz M, Varga B, Priksz D, Gesztelyi R, Tarjanyi V, Kiss R, Szekeres R, Takacs B, Menes A, Balla J, Balla G, Szilvassy J. Szilvassy Z, Juhasz B. Cardioprotective role of BGP-15 in ageing Zucker diabetic fatty rat (ZDF) model: extended mitochondrial longevity. Pharmaceutics 14, 226, 2022.
- Lum-Naihe K, Toedebusch R, Mahmood A, Bajwa J, Carmack T, Kumar SA, Ardhanari S, DeMarco VG, Emter CA, Pulakat L. Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males. Sci Rep 7, 17823, 2017.
- Marfella R, Sardu C, Mansueto G, Napoli C, Paolisso G. Evidence for human diabetic cardiomyopathy. Acta Diabetol 58, 983–988, 2021.
- Marsh SA, Powell PC, Agarwal A, Dell’Italia LJ, Chatham JC. Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis. Am J Physiol Heart Circ Physiol 293, H292–H298, 2007.
- Ng YH, Lamberts RR, Jones PP, Sammut IA, Diffee GM, Wilkins GT, Baldi JC. Sarco/endoplasmic reticulum calcium ATPase activity is unchanged despite increased myofilament calcium sensitivity in Zucker type 2 diabetic fatty rat heart. Sci Rep 12, 16904, 2022.
- Norhammar A, Schenck-Gustafsson K. Type 2 diabetes and cardiovascular disease in women. Diabetologia 56, 1–9, 2013.
- Olsen KB, Axelsen LN, Braunstein TH, Sørensen CM, Andersen CB, Ploug T, Holstein-Rathlou NH, Nielsen MS. Myocardial impulse propagation is impaired in right ventricular tissue of Zucker diabetic fatty (ZDF) rats. Cardiovasc Diabetol 12, 19, 2013.
- Peterson RG, Shaw WN, Neel MA, Little LA, Eichberg J. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. Ilar News 32, 13–15, 1990.
- Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, Hess JF. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13, 18–19, 1996.
- Shmygol A, Bru-Mercier G, Sultan AS, Howarth FC. Distinct effects of obesity and diabetes on the action potential waveform and inward currents in rat ventricular myocytes. Clin Sci 139, 55–67, 2025.
- Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, Mischak H, Jankowski J, Stevens R, Vlahou A, Kossida S, Perco P, Bahlmann FH. Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles. PloS One 7, e51334, 2012.
- Sultan A, Singh J, Howarth FC. Mechanisms underlying electro-mechanical dysfunction in the Zucker diabetic fatty rat heart: a model of obesity and type 2 diabetes. Heart Fail Rev 25, 873–886, 2020.
- Sultan A, Adeghate E, Emerald BS, Qureshi MA, Minhas ST, Howarth FC. Effects of obesity and diabesity on ventricular muscle structure and function in the Zucker rat. Life 12, 1221, 2022a.
- Sultan A, Qureshi MA, Howarth FC. Effects of Isoprenaline on ventricular myocyte shortening and Ca2+ transport in the Zucker rat. Eur J Pharmacol 933, 175263, 2022b.
- Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 225, 75–83 1996.
- van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CFM, Lammertsma AA, van der Velden J, Boer C et al. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol 8, 39, 2009.
- Wachal Z, Szilagyi A, Takacs B, Szabo AM, Priksz D, Bombicz M, Szilvassy J, Juhasz B, Szilvassy Z, Varga B. Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment. Front Pharmacol 12, 650207, 2021.
- Yokoi N, Hoshino M, Hidaka S, Yoshida E, Beppu M, Hoshikawa R, Sudo K, Kawada A, Takagi S, Seino S. A novel rat model of type 2 diabetes: the Zucker fatty diabetes mellitus ZFDM rat. J Diabetes Res 2013, 103731, 2013.
- Zarek-Starzewska A, Klimczak-Tomaniak D, Madrecka A, Sygitowicz G, Janiszewski M, Kuch M. From type 2 diabetes mellitus to diabetic cardiomyopathy - a systematic review on the role of microRNA. Curr Diab Rep 25, 42, 2025.
- Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432, 1994.
- Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Nat Acad Sci USA 97, 1784–1789, 2000.
Language: English
Page range: 111 - 121
Published on: Jul 5, 2026
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Alexandra Zahradnikova, Hira Ijaz, Michal Cagalinec, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.